| 5 | 1/1 | 返回列表 |
| 查看: 783 | 回復(fù): 4 | ||
xiaomao225新蟲(chóng) (正式寫(xiě)手)
|
[求助]
第一句怎么翻譯 已有2人參與
|
|
這句話怎么翻譯?只翻譯這句即可。TSU68 prevents liver metastasis of colon cancer xenografts by modulating the premetastatic niche. 不用翻譯Abstract。 Abstract The aim of this study was to investigate the inhibitory effect of TSU68 [(Z)-5-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoic acid; SU6668], an inhibitor of vascular endothelial growth factor receptor 2, platelet-derived growth factor receptor beta, and fibroblast growth factor receptor 1 (FGFR1), on colon cancer liver metastasis, and to test the hypothesis that TSU68 modulates the microenvironment in the liver before the formation of metastasis. First, we implanted the highly metastatic human colon cancer TK-4 orthotopically into the cecal walls of nude mice, followed by twice-daily administration of TSU68 (400 mg/kg/d) or vehicle. Five weeks of treatment with TSU68 significantly inhibited liver metastasis compared with the control group (P<0.001). Next, we analyzed the gene expression profile in premetastatic liver using microarrays. Microarray and quantitative reverse transcription-PCR analysis showed that mRNA levels for the chemokine CXCL1 were significantly increased in tumor-bearing mice compared with non-tumor-bearing mice. Moreover, CXCL1 expression was significantly decreased by TSU68 treatment. CXCR2 expression was detected predominantly on tumor cells in orthotopic tumors compared with ectopic tumors. The number of migrating neutrophils in premetastatic liver was significantly decreased in the TSU68-treated group (P<0.001). The amount of interleukin-12 (IL-12) p40 in the portal vein was significantly decreased by TSU68 (P=0.02). Blockade of both CXCR2 and IL-12 p40 with a neutralizing antibody significantly inhibited liver metastasis. These results suggest that the CXCL1/CXCR2 axis is important in cancer metastasis and that TSU68 may modulate the premetastatic niche in the target organ through suppression of the inflammatory response, which might be an alternative mechanism used by antiangiogenic agents. |
我試著翻譯下:TSU68通過(guò)調(diào)節(jié)肝臟的結(jié)腸癌細(xì)胞轉(zhuǎn)移前的微環(huán)境以防止或阻止該癌細(xì)胞向肝臟轉(zhuǎn)移或擴(kuò)散。![]() ![]() |
新蟲(chóng) (正式寫(xiě)手)
銅蟲(chóng) (著名寫(xiě)手)
| 5 | 1/1 | 返回列表 |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
![]() |
|
百度網(wǎng)盤(pán) |
360云盤(pán) |
千易網(wǎng)盤(pán) |
華為網(wǎng)盤(pán)
在新窗口頁(yè)面中打開(kāi)自己喜歡的網(wǎng)盤(pán)網(wǎng)站,將文件上傳后,然后將下載鏈接復(fù)制到帖子內(nèi)容中就可以了。 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研]
|
2117205181 2026-03-21 | 7/350 |
|
|---|---|---|---|---|
|
[考研] 303求調(diào)劑 +5 | 安憶靈 2026-03-22 | 6/300 |
|
|
[考研] 一志愿華中科技大學(xué)071000,求調(diào)劑 +4 | 沿岸有貝殼6 2026-03-21 | 4/200 |
|
|
[考研] 0703化學(xué)297求調(diào)劑 +3 | Daisy☆ 2026-03-20 | 3/150 |
|
|
[考研] 330求調(diào)劑0854 +3 | assdll 2026-03-21 | 3/150 |
|
|
[考研] 材料學(xué)學(xué)碩080502 337求調(diào)劑-一志愿華中科技大學(xué) +4 | 順順順mr 2026-03-18 | 5/250 |
|
|
[考研] 316求調(diào)劑 +6 | 梁茜雯 2026-03-19 | 6/300 |
|
|
[考研] 二本跨考鄭大材料306英一數(shù)二 +3 | z1z2z3879 2026-03-17 | 3/150 |
|
|
[考研] 化學(xué)求調(diào)劑 +4 | 臨澤境llllll 2026-03-17 | 5/250 |
|
|
[考研] 265求調(diào)劑 +9 | 梁梁校校 2026-03-17 | 9/450 |
|
|
[考研] 求調(diào)劑 +3 | Ma_xt 2026-03-17 | 3/150 |
|
|
[考研] 一志愿西南交大,求調(diào)劑 +5 | 材化逐夢(mèng)人 2026-03-18 | 5/250 |
|
|
[考研] 321求調(diào)劑 +9 | 何潤(rùn)采123 2026-03-18 | 11/550 |
|
|
[考研]
|
然11 2026-03-19 | 4/200 |
|
|
[考研] 材料學(xué)碩297已過(guò)四六級(jí)求調(diào)劑推薦 +11 | adaie 2026-03-19 | 11/550 |
|
|
[考研] 招收調(diào)劑碩士 +4 | lidianxing 2026-03-19 | 12/600 |
|
|
[考研] 081700化工學(xué)碩調(diào)劑 +3 | 【1】 2026-03-16 | 3/150 |
|
|
[考研] 本科鄭州大學(xué)物理學(xué)院,一志愿華科070200學(xué)碩,346求調(diào)劑 +4 | 我不是一根蔥 2026-03-18 | 4/200 |
|
|
[考研] 一志愿南京大學(xué),080500材料科學(xué)與工程,調(diào)劑 +4 | Jy? 2026-03-16 | 4/200 |
|
|
[考研] 070303 總分349求調(diào)劑 +3 | LJY9966 2026-03-15 | 5/250 |
|